Experimental HIV Vaccine Found In Canada!
Rucuss staffDecember 21, 2011
A group of Canadian scientists have won approval to start testing an experimental HIV vaccine on humans.
Researchers at the University of Western Ontario developed the vaccine, which was approved by the U.S. Food and Drug Administration to start being tested on humans in January. Forty healthy people with HIV will be given the vaccine.
Dr. Chil-Yong Kang, professor of virology at the Schulich School of Medicine and Dentistry at the University of Western Ontario, called the FDA approval a “milestone.”
“We started the basic science research two decades ago,” Kang told the Canadian Star. “The vaccine development, we started 10 years ago. This is incredible for us to get to this stage of development.”
As Reported By The Canadian News:
It is the first preventive HIV vaccine approved for clinical trials to use a whole HIV-1 virus, which has been both killed and genetically engineered, to activate immunity. In this way, the new vaccine is much like the killed whole virus vaccines that are successful against polio, rabies and influenza.
Other HIV vaccines currently in clinical human trials have largely focused on one specific component of HIV to trigger an immune response. Right now, there is no effective HIV vaccine.
“FDA approval for human clinical trials is an extremely significant milestone for our vaccine, which has the potential to save the lives of millions of people around the world by preventing HIV infection,” said Dr. Chil-Yong Kang, professor of virology at the Schulich School of Medicine and Dentistry at the University of Western Ontario, in a release.
The announcement was made Tuesday morning in London.
Let’s pray this vaccine works! It can change so many lives.